ShareHope Medicine Co Ltd (8403) — Cash Flow Reinvestment Rate
ShareHope Medicine Co Ltd (8403) has a Cash Flow Reinvestment Rate of 0.66x as of December 2025, reinvesting NT$75.10 Million (capex NT$39.14 Million plus investments NT$-35.96 Million) from operating cash flow of NT$113.37 Million. Explore ShareHope Medicine Co Ltd (8403) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ShareHope Medicine Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for ShareHope Medicine Co Ltd across 9 annual periods. Also explore how large is ShareHope Medicine Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for ShareHope Medicine Co Ltd. For live market cap and broader valuation context, see how much is ShareHope Medicine Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | NT$244.81 Million | NT$364.12 Million | NT$131.81 Million | ▲ +48.8% |
| 2024 | 0.45x | NT$120.48 Million | NT$266.68 Million | NT$93.02 Million | ▼ -77.0% |
| 2023 | 1.96x | NT$504.81 Million | NT$257.13 Million | NT$277.20 Million | ▼ -52.5% |
| 2022 | 4.14x | NT$2.66 Billion | NT$642.47 Million | NT$1.28 Billion | ▲ +833.9% |
| 2021 | 0.44x | NT$159.51 Million | NT$360.10 Million | NT$152.26 Million | ▼ -15.8% |
| 2020 | 0.53x | NT$377.64 Million | NT$717.74 Million | NT$364.00 Million | ▲ +141.7% |
| 2019 | 0.22x | NT$109.40 Million | NT$502.62 Million | NT$104.17 Million | ▼ -93.6% |
| 2018 | 3.39x | NT$115.10 Million | NT$33.91 Million | NT$102.27 Million | ▼ -2.7% |
| 2017 | 3.49x | NT$218.92 Million | NT$62.76 Million | NT$177.91 Million | — |